Hormone therapy appropriate alternative for treating patients with low-grade prostate cancer

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 1995年 / 30卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：760 / 760
页数：1
相关论文
共 50 条
  • [1] Aggressive therapy unnecessary in low-grade prostate cancer
    Mayor, S
    LANCET ONCOLOGY, 2005, 6 (06): : 359 - 359
  • [2] Hormone therapy and low-grade endometrial stromal sarcoma
    Lee, Wen-Ling
    Lee, Fa-Kung
    Wang, Peng-Hui
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (06) : 445 - 446
  • [3] Stereotactic radiotherapy plus amifostine in patients with low-grade prostate cancer.
    Montchal, Elaine
    Katz, Alan J.
    Witten, Matthew
    ONCOLOGY NURSING FORUM, 2007, 34 (02) : 482 - 483
  • [4] Solitary fibrous tumor of the prostate with accompanying low-grade prostate cancer
    Eich, Marie-Lisa
    Furlano, Kira
    Hilfenhaus, Georg
    Ralla, Bernhard
    Keilholz, Ulrich
    Joosten, Maria
    Rieke, Damian T.
    Schlomm, Thorsten
    Horst, David
    Schallenberg, Simon
    UROLOGY CASE REPORTS, 2024, 57
  • [5] Cancer Detection Rate and Abnormal Interpretation Rate of Prostate MRI in Patients With Low-Grade Cancer
    Nakai, Hirotsugu
    Nagayama, Hiroki
    Takahashi, Hiroaki
    Froemming, Adam T.
    Kawashima, Akira
    Bolan, Candice W.
    Adamo, Daniel A.
    Carter, Rickey E.
    Fazzio, Robert T.
    Tsuji, Shintaro
    Lomas, Derek J.
    Mynderse, Lance A.
    Humphreys, Mitchell R.
    Dora, Chandler
    Takahashi, Naoki
    JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2024, 21 (03) : 387 - 397
  • [6] Low-dose-rate brachytherapy for low-grade prostate cancer
    Raabe, Nils Kristian
    Normann, Marius
    Lilleby, Wolfgang
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2015, 135 (06) : 548 - 552
  • [7] Pharmacokinetic MRI of the Prostate: Parameters for Differentiating Low-Grade and High-Grade Prostate Cancer
    Franiel, T.
    Luedemann, L.
    Taupitz, M.
    Rost, J.
    Asbach, P.
    Beyersdorff, D.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2009, 181 (06): : 536 - 542
  • [8] Low-grade prostate cancer should still be labelled cancer Comment
    Iczkowski, Kenneth A.
    Molina, Mariel
    Egevad, Lars
    Bostwick, David G.
    van Leenders, Geert J. L. H.
    La Rosa, Francisco G.
    van der Kwast, Theodorus
    Berney, Daniel M.
    Evans, Andrew J.
    Wheeler, Thomas M.
    Leite, Katia R. M.
    Samaratunga, Hemamali
    Srigley, John
    Varma, Murali
    Tsuzuki, Toyonori
    Lucia, Marshall Scott
    Crawford, Elward David
    Harris, Richard G.
    Stricker, Philip
    Lawrentschuk, Nathan
    Woo, Henry H.
    Fleshner, Neil E.
    Shore, Neal D.
    Yaxley, John
    Bratt, Ola
    Wiklund, Peter
    Roberts, Matthew
    Cheng, Liang
    Delahunt, Brett
    BJU INTERNATIONAL, 2022, 130 (06) : 741 - 743
  • [9] Low-Grade Prostate Cancer: Time to Stop Calling It Cancer comment
    Eggener, Scott E.
    Berlin, Alejandro
    Vickers, Andrew J.
    Paner, Gladell P.
    Wolinsky, Howard
    Cooperberg, Matthew R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (27) : 3110 - +
  • [10] Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer
    Rounbehler, Robert J.
    Berglund, Anders E.
    Gerke, Travis
    Takhar, Mandeep M.
    Awasthi, Shivanshu
    Li, Weimin
    Davicioni, Elai
    Erho, Nicholas G.
    Ross, Ashley E.
    Schaeffer, Edward M.
    Klein, Eric A.
    Karnes, R. Jeffrey
    Jenkins, Robert B.
    Cleveland, John L.
    Park, Jong Y.
    Yamoah, Kosj
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (11) : 1376 - 1383
12345